Financhill
Sell
50

BPMC Quote, Financials, Valuation and Earnings

Last price:
$97.21
Seasonality move :
12.17%
Day range:
$97.91 - $101.17
52-week range:
$73.04 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.26x
P/B ratio:
18.64x
Volume:
796.7K
Avg. volume:
1.1M
1-year change:
-9.21%
Market cap:
$6.4B
Revenue:
$508.8M
EPS (TTM):
-$2.47

Earnings Data

Next earnings date for BPMC
Aug 01
2025
Most recent earnings per share
$0.01
Beat by $0.45
(May 1/2025)
Consensus Estimate
-$0.44
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BPMC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $171.5M -- -- -$0.51 --
05/01/2025 Q1 $156.9M $149.4M $0.01 -$0.44 $0.45
02/13/2025 Q4 $145.2M $146.4M -$0.79 -$0.73 -$0.06
10/30/2024 Q3 $127.5M $128.2M -$0.89 -$0.96 $0.07
08/01/2024 Q2 $103.9M $138.2M -$0.80 -$1.25 $0.45
05/02/2024 Q1 $81.4M $96.1M $1.40 -$1.67 $3.07
02/15/2024 Q4 $67.1M $72M -$1.82 -$2.06 $0.24
10/26/2023 Q3 -- -- -$2.20 -$2.33 $0.13
08/02/2023 Q2 -- -- -$2.19 -$2.49 $0.30
05/04/2023 Q1 -- -- -$2.15 -$2.62 $0.47
02/16/2023 Q4 -- -- -$2.65 -$2.61 -$0.04
11/01/2022 Q3 -- -- -$2.23 -$2.49 $0.26
08/02/2022 Q2 -- -- -$2.68 -$2.26 -$0.42
05/03/2022 Q1 -- -- -$1.79 -$1.85 $0.06
02/16/2022 Q4 -- -- -$5.40 -$1.57 -$3.83
10/28/2021 Q3 -- -- -$2.00 -$1.66 -$0.34
07/29/2021 Q2 -- -- -$1.86 -$1.92 $0.05
04/29/2021 Q1 -- -- -$1.72 -$1.82 $0.10
02/17/2021 Q4 -- -- -$1.53 -$1.55 $0.02
10/29/2020 Q3 -- -- $11.16 $9.30 $1.86
07/30/2020 Q2 -- -- -$2.28 -$2.08 -$0.20
05/06/2020 Q1 -- -- -$2.11 -$2.01 -$0.10
02/13/2020 Q4 -- -- -$1.35 -$1.73 $0.38
11/05/2019 Q3 -- -- -$1.93 -$2.17 $0.24
08/01/2019 Q2 -- -- -- -$1.90 --
05/09/2019 Q1 -- -- -- -$1.89 --
02/26/2019 Q4 -- -- -- -$1.72 --
10/30/2018 Q3 -- -- -- -$1.61 --
08/01/2018 Q2 -- -- -- -- --
05/02/2018 Q1 -- -- -- -- --
02/21/2018 Q4 -- -- -- -- --
10/31/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
05/09/2017 Q1 -- -- -- -- --
03/09/2017 Q4 -- -- -- -- --
11/10/2016 Q3 -- -- -- -- --
08/09/2016 Q2 -- -- -- -- --
05/10/2016 Q1 -- -- -- -- --
03/14/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --
09/10/2015 Q2 -- -- -- -- --

Blueprint Medicines Earnings Questions

  • How Much did Blueprint Medicines Generate in Revenue Last Quarter?

    Blueprint Medicines reported $149.4M worth of top line sales in its most recent quarter.

  • Did Blueprint Medicines Beat Earnings Last Quarter?

    Blueprint Medicines announced earnings per share of $0.01 which represents a beat of analyst forecast a -$0.44 per share.

  • Is Blueprint Medicines Profitable?

    Blueprint Medicines reported $146.6M that represents $2.20 per share over the last quarter.

  • What is the Analyst Consensus for Blueprint Medicines EPS Next Year?

    Blueprint Medicines's earnings are forecast to decrease from -$1.07 per share to -$1.05 per share next year representing a decrease of -58.51%.

  • When is Blueprint Medicines's Earnings Date?

    Blueprint Medicines's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 9.31% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 9.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock